Uncovering repurposed medicines to fight liver fibrosis
Google DeepMind ● Covered by 3 sources
Researchers at Stanford University used an AI tool called Co-Scientist to identify existing medicines that could treat liver fibrosis, a scarring condition that kills over 1.4 million people annually. When tested against human liver cells, two of three AI-selected drug candidates blocked fibrosis progression, while the cancer drug vorinostat blocked 91% of a damage response driving liver scarring. The findings suggest that drugs altering gene activity patterns warrant clinical investigation as potential treatments for the condition.
Why it matters
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
